The first step of the process will involve construction of an in vivo center for animal research, slated for completion in 2018. And Roche--the top R&D spender in the world with a 2013 budget of $10.3 billion--plans to clear away older buildings to make way for a new office tower as part of a wider building plan that will cost a total of $3.2 billion.
Thursday, October 23, 2014
Because they are worth it!
Labels:
Big Pharma,
bubble,
deconstruction,
macro economy,
nice idea,
numbers,
paradigm,
real science
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment